UCLA Health’s Comprehensive Menopause Program has two complementary public records: one explains the clinical service, and another explains what a patient can expect before and after an appointment. That combination provides a concrete basis for reviewing the program. It is different from inferring a clinical offering from a general menopause FAQ.
The pages checked September 28, 2026 describe a health-system consultation supported by an advance questionnaire and a network of specialists. They do not sell a fixed estrogen package or establish a standard price. This review concentrates on how to request the named program, the scope of its initial assessment and the boundaries of the published follow-up description.
UCLA documents an individualized menopause consultation with advance intake and follow-up. Exact appointment location, remote eligibility, charges and prescriptions still require confirmation.
Request the named program explicitly
The patient-information page lists 310-794-7274 and asks callers to specify an appointment with a Comprehensive Menopause Program provider. It also says current patients can manage appointments through myUCLAhealth. Those instructions distinguish the program from a generic gynecology booking.
A portal’s scheduling function does not establish that a new patient can complete the initial evaluation remotely. The reviewed records do not verify a specific appointment slot, location or state-by-state virtual eligibility. The Stanford Health Care review provides a useful comparison because its treatment page explicitly mentions video and Bay Area in-person access. Each institution’s own access wording should control the comparison.
The questionnaire is a substantial preparation step
UCLA says it sends a comprehensive health questionnaire before the appointment, estimates that completion takes 30 to 45 minutes and asks for it at least seven days before the visit. These are the program’s published preparation expectations, not a universal rule for menopause care or a questionnaire offered by this review site.
The Northwestern Medicine review describes another program that requires advance questionnaire review, but UCLA gives more specific preparation timing in the reviewed record. Someone who needs language, accessibility or record-transfer assistance can ask the program how that is arranged. Finishing a questionnaire does not establish that the clinician has accepted a requested medicine or that all necessary records have already been received.
The first visit is broader than one symptom
The clinical-services page describes a consultation addressing menopause-related symptoms and health considerations involving bone, breast, cognition, cardiovascular health, mood, sleep and the genitourinary system. It says options are discussed and an individualized plan developed. This is the program’s stated assessment scope, not a guarantee that each domain receives a separate test.
The questions-before-starting-estrogen guide can help a reader bring a clear reason for the consultation. It is useful to distinguish the most disruptive observed concern from a broader prevention question. The public page cannot determine which symptoms have a menopausal explanation or which assessments would be appropriate for an individual.
A specialist network does not imply a single bundled visit
UCLA describes a collaborative network that includes areas such as cancer survivorship, bone health, cardiovascular health, sexual health and sleep. The patient page says people needing specialized care can be connected with interdisciplinary specialists. The conditional nature of that referral is important: every patient is not automatically scheduled with every listed service.
A practical question is whether another consultation would occur within the program appointment or through a separate service with its own scheduling and charges. The University of Utah Health review also examines a broader midlife program, but its published process is different. A large network can describe available expertise without establishing the sequence or cost of care for a particular patient.
Treatment discussion leaves the estrogen details open
The clinical page says the team discusses treatment options, but the two reviewed program records do not specify a guaranteed estrogen product, strength, pharmacy or supply amount. That prevents a precise product comparison at this stage. A program capable of evaluating menopause concerns is not the same kind of offer as a checkout page naming a medicine and payment period.
The local-versus-systemic guide and patch-versus-pill guide help clarify terms that may come up if hormone treatment is considered. They cannot select a route for the reader. The relevant clinical questions concern the purpose of a proposed treatment, its individual suitability and what monitoring or follow-up the prescribing professional would explain.
Follow-up is described, but not priced
UCLA’s patient information says follow-up appointments are scheduled as needed and that a yearly comprehensive health assessment is also arranged. This is a published service expectation, not a personal instruction from this review to return at a particular interval. It also does not establish that future visits are prepaid or included in the initial appointment charge.
No numerical consultation fee or complete annual cost was found in the reviewed program pages. Billing questions should distinguish the initial visit, subsequent appointments and any separately referred services. The mention of a yearly assessment is therefore useful for understanding continuity, but it should not be converted into an annual membership product or a promise about insurance coverage.
The strongest comparison is preparation plus continuity
UCLA provides unusually concrete public intake information: the named program request, advance questionnaire, initial consultation and stated follow-up pattern. These details make it possible to ask focused administrative questions before committing time to an appointment. They do not independently demonstrate appointment quality, treatment success or shorter waiting times than another provider.
The remaining practical points are the selected clinician and location, available appointment format, expected charges and the route for questions after the visit. This review did not submit medical information or book care. It treats UCLA as a documented health-system option with a defined preparation process, while leaving personal diagnosis and treatment decisions with the professionals responsible for the consultation.
Sources & reading
Source check dates appear with each record below. Provider pages describe their own services; they do not establish clinical superiority.
- UCLA Health Comprehensive Menopause Program: Clinical Services ↗Primary health-system service record; published clinical scope and appointment limitations · Checked 2026-09-28
- UCLA Health Comprehensive Menopause Program: Patient Information ↗Primary health-system service record; published clinical scope and appointment limitations · Checked 2026-09-28